Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Leila Godfrey

Postdoctoral Immunologist

Immunologist for the Oxford AstraZeneca Covid-19 vaccine clinical trial. Previous academic role working on projects using the multiomics platform BD Rhapsody in The Diabetes and Inflammation Laboratory, University of Oxford. Industry experience in T Cell Receptor Biotechnology for cancer therapies at Immunocore. Doctoral research on the role of Natural Killer Cells in autoimmune arthritis